Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.
Weiss A, Delavenne E, Matias C, Lagler H, Simon D, Li P, Hansen JU, Dos Santos TP, Jana B, Priemel P, Bangert C, Bauer M, Eberl S, Nussbaumer-Pröll A, Anne Österreicher Z, Matzneller P, Quint T, Weber M, Nielsen HM, Rades T, Johansen HK, Westh H, Kim W, Mylonakis E, Friis C, Guardabassi L, Pace J, Lundberg CV, M'Zali F, Butty P, Sørensen N, Nielsen HB, Toft-Kehler R, Guttman-Yassky E, Stingl G, Zeitlinger M, Sommer M. Weiss A, et al. Clin Transl Med. 2022 May;12(5):e790. doi: 10.1002/ctm2.790. Clin Transl Med. 2022. PMID: 35522900 Free PMC article. Clinical Trial.
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.
Brunner PM, Silverberg JI, Guttman-Yassky E, Paller AS, Kabashima K, Amagai M, Luger TA, Deleuran M, Werfel T, Eyerich K, Stingl G; Councilors of the International Eczema Council. Brunner PM, et al. J Invest Dermatol. 2017 Jan;137(1):18-25. doi: 10.1016/j.jid.2016.08.022. Epub 2016 Oct 20. J Invest Dermatol. 2017. PMID: 27771048 Free article. Review.
Topical agents for the treatment of atopic dermatitis.
Diaz A, Guttman-Yassky E. Diaz A, et al. Expert Rev Clin Immunol. 2019 Apr;15(4):369-382. doi: 10.1080/1744666X.2019.1564038. Epub 2019 Jan 8. Expert Rev Clin Immunol. 2019. PMID: 30587053 Review.
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis.
Callewaert C, Nakatsuji T, Knight R, Kosciolek T, Vrbanac A, Kotol P, Ardeleanu M, Hultsch T, Guttman-Yassky E, Bissonnette R, Silverberg JI, Krueger J, Menter A, Graham NMH, Pirozzi G, Hamilton JD, Gallo RL. Callewaert C, et al. J Invest Dermatol. 2020 Jan;140(1):191-202.e7. doi: 10.1016/j.jid.2019.05.024. Epub 2019 Jun 25. J Invest Dermatol. 2020. PMID: 31252032 Free PMC article. Clinical Trial.
Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial.
Bissonnette R, Pavel AB, Diaz A, Werth JL, Zang C, Vranic I, Purohit VS, Zielinski MA, Vlahos B, Estrada YD, Saint-Cyr Proulx E, Ports WC, Guttman-Yassky E. Bissonnette R, et al. J Allergy Clin Immunol. 2019 Nov;144(5):1274-1289. doi: 10.1016/j.jaci.2019.06.047. Epub 2019 Aug 13. J Allergy Clin Immunol. 2019. PMID: 31419544 Free article. Clinical Trial.
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis.
Dubin C, Del Duca E, Guttman-Yassky E. Dubin C, et al. Expert Rev Clin Immunol. 2021 Aug;17(8):835-852. doi: 10.1080/1744666X.2021.1940962. Epub 2021 Jul 21. Expert Rev Clin Immunol. 2021. PMID: 34106037 Review.
423 results